Loading...
Loading...
Cabot Corporation
CBT has had a very strong year and is looking to finish the year out in the same fashion.
In a research report Jefferies & Company, Inc. writes "With more favorable fundamentals likely into 2011, limited balance sheet risk, a more favorable raw material environment, and ongoing structural improvements, we reiterate our Buy rating.
Given likely favorable volumes in Q4, we are raising 2010E EPS $0.05 to $2.85. To better reflect both the likely ongoing tantalum inventory liquidation ($0.06-$0.10/quarter tailwind while it lasts) and the CEC milestones ($0.02-$0.05 benefit in 2010), we are raising 2011E $0.10 to $2.95 and lowering 2012E $0.10 to $3.10."
CBT Closed Tuesday at $32.97
Don't miss these trading ideas!© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in